FDA Restricts Use of Monoclonal Antibody Treatments Without Explanation While Ignoring the SuccessesUnderground USAJan 26, 2022∙ Paid1ShareThrough it all, we must start openly and forcefully questioning the motives behind every decision made; every directive issued by the Food & Drug Administration (FDA) and the Center for Disease Contr…This post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext